2D·

Should one

With $HIMS (-26,15%) buy the dip now, or wait for the figures? I had already expected this sell-off to 45-50 and had already posted it, but only with the figures.

10 Comentários

The W.@thewolfofallstreetz

I think it's good that the news came today - it was only a matter of time. Now the management will have the opportunity to comment on the issue on Monday. So far, the management has been convinced that the long-term success of Hims & Hers is not dependent on the GLP-1s. I assume that this will be confirmed again. Personally, I am holding my position, buying and not selling.

•

Chris@Multibagger

@thewolfofallstreetz and what would you do if you were not yet invested, now or after the figures?

••

The W.@thewolfofallstreetz

@Multibagger That depends on your strategy, portfolio structure and risk appetite. Personally, I think the risk/reward ratio is currently not as good as it was a few weeks/months ago. It had a strong run and is still valued at 12x P/S. As a long term investor I would wait for the call and the new guidance from management - after that you can still lay your cards on the table. If you are a trader, you can bet on one direction or the other in the short term.

•

Tino@parlania

There is still a lot of room for improvement ...

•

Joschi 💎.@ETF_Jesus

I bought a knockout long and let's see what happens xD

•

Chris@Multibagger

@ETF_Jesus Which Ko threshold did you use?

••

Joschi 💎.@ETF_Jesus

@Multibagger 39usd

••

market_expert_gbtws@market_expert_gbtws

Short !

••

AdriInvests@AdriInvests

I bought more. Let's see what happens 🤷‍♂️

••

Smudo@Smudeo

The reason for this is the decision by the US Food and Drug Administration (FDA) in connection with the popular weight loss products from Novo Nordisk. The two pharmaceutical giants were unable to ramp up production as quickly as the products were in demand. As a result, the US Food and Drug Administration (FDA) classified Ozempic and Wegovy as being in short supply and granted pharmacies such as Hims & Hers special permission to produce exact replicas of the drugs.

••